May 24, 2021 | Press Releases
New White Paper Identifies Patent Thickets as Barrier to US Biosimilars Market and Domestic Manufacturing Alex Brill and Christy Robinson | Washington, DC The white paper offers policy options to improve access to affordable biosimilar medicines. WASHINGTON,...
Sep 14, 2020 | Press Releases
New Report Shows Brand Drug Product Hopping Costs Billions for Patients and Healthcare System Each Year Alex Brill | Washington, DC Today, Matrix Global Advisors (MGA) released a new report, “The Cost of Brand Drug Product Hopping,” commissioned by the Coalition for...
